Remdesivir Intermediate CAS 1354823-36-1 COVID-19 N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester
Manufacturer Commercial Supple Remdesivir et intermedia cum High Quality
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl((S)-(perfluorophenoxys)(phosphoryl)-L-alaninatum CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy) phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolitae (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermedia CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Nomen chemicum | N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester |
Synonyma | Remdesivir Medius;Remdesivir Side Chain;Remdesivir p-NitroPhenoxy L-Alanine Impurity;Remdesivir immunditia 4;Remdesivir-002;(S) -2-Ethylbutyl 2-(((S)-(4-nitrophenoxy)(phenoxy)-phosphoryl)-amino)propanoatum |
CAS Number | 1354823-36-1 |
CATTUS Number | RF-PI297 |
Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
Formulae hypotheticae | C21H27N2O7P |
M. Pondus | 450.42 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad fere album pulveris |
Lepidium sativum | IR, HPLC |
Damnum in Siccatio | ≤1.0% |
una immunditia | ≤0.50% |
Metalla gravis | ≤20ppm |
Puritas | ≥98.0% |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Remdesiviri (CAS 1809249-37-3);COVID 19 |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester (CAS 1809249-37-3, GS-5734), quod medicamentum novum antivirale investigationis originaliter est ad curationem morbi virus virus et Marburg infectio virium Marburg, et postea etiam inventa est ut ostenderet actionem antiviralem contra coronaviroses (eg SARS-Cov-2/. Covid 19).In ingruente novo Coronaviro Morbus 2019 (COVID-19), Remdesivir (CAS 1809249-37-3) est unus e productis investigationis CoVID-19 affinis.Remdesivir, sub noto nomine Veklury venditus, est medicamentum latum-spectrum antivirale a comitatu Gilead Scientiarum biopharmaceutico elaboratum.Datur per iniectionem in venam.Durante COVID-19 pandemico, Remdesivir probatus est vel auctoritate usus ad subitum tractandum COVID-19 in regionibus circiter 50.Renovatae normae a Mundi Salus Organizatio mense Novembri 2020 includunt commendationem conditionalem contra usum Remdesiviri ad tractandum de COVID-19.